Market – Overview
The global antinuclear antibody test market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 12.2% during the forecast period (2022-2029).
The anti-nuclear antibody test (ANA) or FANA (fluorescent anti-nuclear antibody) is a blood test that detects the presence of auto-antibodies in the serum, which are antibodies produced by the body against its cells. The human immune system recognizes foreign things such as bacteria, viruses, fungus, and other microbes in normal circumstances and mounts an immune response against them. Many antibodies are produced during this immune reaction, which binds and kills any foreign particles in the body.
Technological advancements and increased R&D funding for new products are expected to drive market growth.
The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) established a classification criterion for systemic lupus erythematosus (SLE) in 2019, which suggested that immunofluorescence testing on solid-phase anti-nuclear antibody screening immunoassay and HEp-2 cells with equal performance was highly preferred. Moreover, the market for anti-nuclear antibody testing is growing due to government healthcare insurance, an increase in autoimmune disorders awareness campaigns, and reimbursement regulations. For instance, The World Lupus Federation (WLF) collaborates with roughly 250 lupus organizations from 75 countries across six continents to assist lupus patients. WLF works to improve public awareness about Lupus and provide better healthcare for those who suffer from the disease. Thus, the market is expected to drive in the forecast period from the above statements.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/antinuclear-antibody-test-market
However, there are rigorous requirements for medical device clearance in developing economies and the demand of large resources to purchase high-priced equipment, a scarcity of competent medical personnel, and a lack of awareness of the disease and effective treatment. Thus, the market is expected to get hampered in the forecast period from the above statements.
- Reagents & Assay Kits
- Multiplex Assay
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
Major key players in the antinuclear antibody test market are Abbott Laboratories (Alere Inc), BioVision Inc, Antibodies Incorporated, PerkinElmer Inc, Zeus Scientific, Inc., Bio-Rad Laboratories, Inc., Inova Diagnostics, Thermo Fisher Scientific, Inc., Trinity Biotech plc. and Immuno Concepts.
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.